Skip to main content

CPT2

Function

Involved in the intramitochondrial synthesis of acylcarnitines from accumulated acyl-CoA metabolites (PubMed:20538056, PubMed:24780397). Reconverts acylcarnitines back into the respective acyl-CoA esters that can then undergo beta-oxidation, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion. Active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters (PubMed:20538056).

Involvement in disease

Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced

CPT2D

An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are exacerbated by prolonged exercise, fasting, cold, or viral infection. CPT2DM affects most frequently children or young adults, and severity of attacks is highly variable. Myoglobinuria can cause kidney failure and death.

None

The disease is caused by variants affecting the gene represented in this entry.

Carnitine palmitoyltransferase 2 deficiency, infantile

CPT2DI

An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy.

None

The disease is caused by variants affecting the gene represented in this entry.

Carnitine palmitoyltransferase 2 deficiency, lethal neonatal

CPT2DLN

An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation with fatal outcome, presenting shortly after birth. It is characterized by respiratory distress, seizures, altered mental status, hepatomegaly, cardiomegaly, cardiac arrhythmia, and, in many cases, dysmorphic features, renal dysgenesis, and migration defects. recessive.

None

The disease is caused by variants affecting the gene represented in this entry.

Encephalopathy, acute, infection-induced, 4

IIAE4

A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high-grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder.

None

Disease susceptibility is associated with variants affecting the gene represented in this entry. CPT2 polymorphic variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855).

Pathway

Lipid metabolism; fatty acid beta-oxidation.

Sequence similarities

Belongs to the carnitine/choline acetyltransferase family.

Cellular localization

  • Mitochondrion inner membrane
  • Peripheral membrane protein
  • Matrix side

Alternative names

  • CPT1
  • CPT1
  • CPT2
  • Carnitine palmitoyltransferase II
  • CPT II

Target type

Proteins

Primary research area

Metabolism

Molecular weight

73777Da

We found 5 products in 2 categories

Primary Antibodies

Target

Reactive species

Proteins & Peptides

Target

Species of origin

Nature

Search our catalogue for 'CPT2' (5)

Products

ab181114

Anti-CPT2 antibody [EPR13626] - C-terminal

RabMAb
Recombinant
KO Validated

ab231162

Anti-CPT2 antibody [EPR13626] - BSA and Azide free

RabMAb
Recombinant
KO Validated